Literature DB >> 27853653

Dense breast tissue in postmenopausal women is associated with a pro-inflammatory microenvironment in vivo.

Annelie Abrahamsson1, Anna Rzepecka2, Thobias Romu3, Magnus Borga3, Olof Dahlqvist Leinhard4, Peter Lundberg4, Johan Kihlberg5, Charlotta Dabrosin1.   

Abstract

Inflammation is one of the hallmarks of carcinogenesis. High mammographic density has been associated with increased risk of breast cancer but the mechanisms behind are poorly understood. We evaluated whether breasts with different mammographic densities exhibited differences in the inflammatory microenvironment. Postmenopausal women attending the mammography-screening program were assessed having extreme dense, n = 20, or entirely fatty breasts (nondense), n = 19, on their regular mammograms. Thereafter, the women were invited for magnetic resonance imaging (MRI), microdialysis for the collection of extracellular molecules in situ and a core tissue biopsy for research purposes. On the MRI, lean tissue fraction (LTF) was calculated for a continuous measurement of breast density. LTF confirmed the selection from the mammograms and gave a continuous measurement of breast density. Microdialysis revealed significantly increased extracellular in vivo levels of IL-6, IL-8, vascular endothelial growth factor, and CCL5 in dense breast tissue as compared with nondense breasts. Moreover, the ratio IL-1Ra/IL-1β was decreased in dense breasts. No differences were found in levels of IL-1β, IL-1Ra, CCL2, leptin, adiponectin, or leptin:adiponectin ratio between the two breast tissue types. Significant positive correlations between LTF and the pro-inflammatory cytokines as well as between the cytokines were detected. Stainings of the core biopsies exhibited increased levels of immune cells in dense breast tissue. Our data show that dense breast tissue in postmenopausal women is associated with a pro-inflammatory microenvironment and, if confirmed in a larger cohort, suggests novel targets for prevention therapies for women with dense breast tissue.

Entities:  

Keywords:  Cytokines; MRI; mammary gland; mammography; microdialysis

Year:  2016        PMID: 27853653      PMCID: PMC5087296          DOI: 10.1080/2162402X.2016.1229723

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  51 in total

Review 1.  Microdialysis - an in vivo technique for studies of growth factors in breast cancer.

Authors:  Charlotta Dabrosin
Journal:  Front Biosci       Date:  2005-05-01

2.  Nonsteroidal anti-inflammatory drug use and breast cancer risk.

Authors:  M Cotterchio; N Kreiger; M Sloan; A Steingart
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-11       Impact factor: 4.254

3.  Variability of vascular endothelial growth factor in normal human breast tissue in vivo during the menstrual cycle.

Authors:  Charlotta Dabrosin
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

4.  Breast cancer and hormone-replacement therapy in the Million Women Study.

Authors:  Valerie Beral
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

Review 5.  Regulation of estrogen synthesis in postmenopausal women.

Authors:  Atul Purohit; Michael J Reed
Journal:  Steroids       Date:  2002-11       Impact factor: 2.668

Review 6.  Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.

Authors:  Jürgen Geisler
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

7.  Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.

Authors:  Randall E Harris; Rowan T Chlebowski; Rebecca D Jackson; David J Frid; Joao L Ascenseo; Garnet Anderson; Aimee Loar; Rebecca J Rodabough; Emily White; Anne McTiernan
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

8.  Increase of free insulin-like growth factor-1 in normal human breast in vivo late in the menstrual cycle.

Authors:  Charlotta Dabrosin
Journal:  Breast Cancer Res Treat       Date:  2003-07       Impact factor: 4.872

9.  Breast cancer and NSAID use: a meta-analysis.

Authors:  S A Khuder; A B Mutgi
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

10.  Mammographic density is related to stroma and stromal proteoglycan expression.

Authors:  Salem Alowami; Sandra Troup; Sahar Al-Haddad; Iain Kirkpatrick; Peter H Watson
Journal:  Breast Cancer Res       Date:  2003-07-23       Impact factor: 6.466

View more
  7 in total

1.  Associations of aspirin and other anti-inflammatory medications with mammographic breast density and breast cancer risk.

Authors:  Lusine Yaghjyan; Akemi Wijayabahu; A Heather Eliassen; Graham Colditz; Bernard Rosner; Rulla M Tamimi
Journal:  Cancer Causes Control       Date:  2020-05-31       Impact factor: 2.506

2.  Breast density is strongly associated with multiparametric magnetic resonance imaging biomarkers and pro-tumorigenic proteins in situ.

Authors:  Peter Lundberg; Mikael F Forsgren; Jens Tellman; Johan Kihlberg; Anna Rzepecka; Charlotta Dabrosin
Journal:  Br J Cancer       Date:  2022-09-22       Impact factor: 9.075

3.  Dietary flaxseed and tamoxifen affect the inflammatory microenvironment in vivo in normal human breast tissue of postmenopausal women.

Authors:  Gabriel Lindahl; Annelie Abrahamsson; Charlotta Dabrosin
Journal:  Eur J Clin Nutr       Date:  2019-01-28       Impact factor: 4.016

4.  Increased nutrient availability in dense breast tissue of postmenopausal women in vivo.

Authors:  Annelie Abrahamsson; Anna Rzepecka; Charlotta Dabrosin
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

5.  Breast Density and Estradiol Are Major Determinants for Soluble TNF-TNF-R Proteins in vivo in Human Breast Tissue.

Authors:  Jimmy Ekstrand; Maja Zemmler; Annelie Abrahamsson; Peter Lundberg; Mikael Forsgren; Charlotta Dabrosin
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

6.  Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women.

Authors:  Annelie Abrahamsson; Alessandra Capodanno; Anna Rzepecka; Charlotta Dabrosin
Journal:  Oncotarget       Date:  2017-09-15

7.  Equal Pro-inflammatory Profiles of CCLs, CXCLs, and Matrix Metalloproteinases in the Extracellular Microenvironment In Vivo in Human Dense Breast Tissue and Breast Cancer.

Authors:  Annelie Abrahamsson; Anna Rzepecka; Charlotta Dabrosin
Journal:  Front Immunol       Date:  2018-01-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.